English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Jul 30, 2026

Sanofi CEO outlines cautious approach to Phase 3 drug development decisions
+ Pharmaceuticals
Patient Daily | Jul 30, 2026

Researchers announce new OpenABE gene editor with up to 36-fold efficiency improvement
+ Pharmaceuticals
Patient Daily | Jul 29, 2026

Study links problematic internet use to higher stress and worse mood
+ Pharmaceuticals
Patient Daily | Jul 29, 2026

Researchers develop AI model to classify diabetes into four diagnostic categories
+ Pharmaceuticals
Patient Daily | Jul 29, 2026

FDA advisers vote against Capricor’s Duchenne therapy after contentious meeting
+ Pharmaceuticals
Patient Daily | Jul 29, 2026

Researchers identify protein pathway that may improve glioblastoma treatment options
+ Pharmaceuticals
Patient Daily | Jul 29, 2026

AI-enabled tool linked to fewer deaths among high-risk hospitalized patients, study finds
+ Pharmaceuticals
Patient Daily | Jul 29, 2026

Study links early-life sugar restriction to lower dementia risk in later years

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes